Development of Drugs for relapse prevention - a breakthrough drug for the treatment of patients with recurrent forms of multiple sclerosis arose from the method developed by Dr. Elizabeth Wayner beginning in late 1980. Known as Tysabri ® (Natalizumab), drug uses antibodies - that is, the type of immune system protein that binds exclusively to another protein - prevent inflammation associated with multiple sclerosis. Tysabri may also be useful for patients with other autoimmune diseases such as lupus, Crohn's disease and rheumatoid arthritis, and melanoma in a severe form of skin cancer. Transplantation of stem cells - researchers lasix heart rate are clinical trials to explore the possibility of high-dose chemotherapy and stem cell transplantation - the standard treatment of leukemia and other blood cancer - in the treatment of severe autoimmune diseases including multiple sclerosis and scleroderma (also known as systemic sclerosis). In transplantation, it may be possible todeplete reactive cells, causing the immune system attack the body. The first results were promising, causing extensive research. .
No comments:
Post a Comment